Aardvark released exploratory data from its stopped Phase 3 HERO trial in Prader-Willi syndrome after FDA lifted the hold, and plans a redesigned Phase 3.
|Articles|October 15, 2021
People and Business News — 10/21
Advertisement
People news
Kimberly Tableman joined Castor as Chief Clinical Development Officer and Anna Wozniak as Chief Financial & Development Officer.
AiCure has added the following new senior team members: Brian Jung as Chief Financial Officer; Lynne Rowlandas Chief Marketing Officer, Aaron Masino, PhD, as Senior Director of Digital Biomarker Development; Nina Tayloras Director, Strategic Partnerships; and Viren Kavia as Director, Strategic Partnerships.
Curavit Clinical Research announced the appointments of Jay Collier, as Chief Operating Officer, and Candice Del Rio, as Director of Clinical Operations.
uMotif announced Steve Rosenberg was appointed to CEO.
Worldwide Clinical Trials announced the appointment of Dr. Wolfram C.M. Dempke, as Vice President, Scientific Solutions, Hematology & Oncology.
Parexel announced the appointment of Stephen Pyke as the company’s Executive Vice President, Clinical Data and Digital Services.
Medable Inc. announced the hiring of Orlando Baeza as the company’s first chief marketing officer.
Anju Software hired a new Vice President of Operations, Michael Keens.
Business news
Futura Medical is partnering with OCT Clinical to run its FM71 study in Eastern Europe and the USA.
Remarque Systems’ platform is the industry’s first patented trail-audited real-time risk-based quality management system.
Recognition
PHASTAR was announced as a joint winner of the 2021 Innovation in the Management of Clinical Data Award by the Association for Clinical Data Management.
Anju Software has been named by Gartner as a sample vendor in four categories in its 2021 Hype Cycle Life Sciences Research and Development report and Commercial Operations report.
Elligo Health Research was named winner of the 2021 Site Tank Award at Society for Clinical Research Site’s recent 2021 Global Site Solutions Summit for their virtual AI-powered clinical trial engagement assistant, Root.
Advertisement
Related to this article
Clinical trials capture data faster than ever, but the real bottleneck is the distance between data capture and a decision teams can trust.
In today’s ACT Brief, we examine why the future of AI in trials is a trusted orchestration system rather than a single model, how coordinators rate eSource-enabled workflows, and what a bipartisan bill proposes for reusable trial networks.
The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.
Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
2
Bipartisan Bill Would Build Reusable Clinical Trial Networks, With a Focus on Rare Disease
3
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
4
Where AI Governance in Clinical Development Falls Short
5